`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home3 Drug Databases4 Orange Book5
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Search results from the "OB_Disc" table for query on "021664."
`
`BROMFENAC SODIUM
`Active Ingredient:
`SOLUTION/DROPS;OPHTHALMIC
`Dosage Form;Route:
`XIBROM
`Proprietary Name:
`BAUSCH AND LOMB INC
`Applicant:
`EQ 0.09% ACID
`Strength:
`N021664
`Application Number:
`001
`Product Number:
`Mar, 24, 2005
`Approval Date:
`DISCN
`RX/OTC/DISCN:
`Patent and Exclusivity Info for this product: View
`Active Ingredient:
`BROMFENAC SODIUM
`Dosage Form;Route:
`SOLUTION/DROPS;OPHTHALMIC
`Proprietary Name:
`BROMDAY
`Applicant:
`BAUSCH AND LOMB INC
`Strength:
`EQ 0.09% ACID
`Application Number:
`N021664
`Product Number:
`002
`Approval Date:
`Oct, 16, 2010
`RX/OTC/DISCN:
`DISCN
`Patent and Exclusivity Info for this product: View
`Return to Electronic Orange Book Home Page6
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data Monthly
`Generic Drug Product Information & Patent Information Daily
`Orange Book Data Updated Through September 2015
`Patent and Generic Drug Product Data Last Updated November 09, 2015
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading
`Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website
`Policies
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=021664&TABLE1=OB_Disc
`
`1/2
`
`Page 1 of 2
`
`SENJU EXHIBIT 2164
`LUPIN v. SENJU
`IPR2015-01097
`
`
`
`11/10/2015
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1888INFOFDA (18884636332)
`Contact FDA
`
`
`
`
`
`
`
`
`
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=021664&TABLE1=OB_Disc
`
`2/2
`
`Page 2 of 2